Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2025-06-23 00:00:00 ET · period of report 2025-06-18 · accession 0000950170-25-089052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-23 | 2025-06-18 | RYTM | Mathers Edward T | Dir | M - OptEx | — | +4,000 | 7,000 | +133% | — |
| D | 2025-06-23 | 2025-06-18 | RYTM | Mathers Edward T | Dir | M - OptEx | $0.00 | -4,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-18 | M | A | 4,000 | — | 7,000 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 2 | Derivative | Restricted Stock Units | 2025-06-18 | M | D | 4,000 | $0.00 | 0 | D | — · — to — | 4,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date. |